Clinical Trial Detail

NCT ID NCT03505710
Title DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Daiichi Sankyo, Inc.
Indications

non-small cell lung carcinoma

Therapies

DS-8201a

Age Groups: senior adult

Additional content available in CKB BOOST